LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 83

Search options

  1. Article: A Case Report of Myoclonus-Dystonia with Isolated Myoclonus Phenotype and Novel Mutation Successfully Treated with Deep Brain Stimulation.

    Besa Lehmann, Valentina / Rosenbaum, Marc / Bulman, Dennis E / Read, Tara / Verhagen Metman, Leo

    Neurology and therapy

    2020  Volume 9, Issue 1, Page(s) 187–191

    Abstract: Introduction: Myoclonus-dystonia is an inherited disorder characterized by a combination of myoclonic jerks and dystonia. Mutations in the epsilon-sarcoglycan gene (SGCE) represent the main known genetic cause. In the last few years, deep brain ... ...

    Abstract Introduction: Myoclonus-dystonia is an inherited disorder characterized by a combination of myoclonic jerks and dystonia. Mutations in the epsilon-sarcoglycan gene (SGCE) represent the main known genetic cause. In the last few years, deep brain stimulation (DBS) has shown significant promise in treating these patients. There is only one report in the literature of a patient with positive SGCE mutation and isolated myoclonus phenotype who has been successfully treated with DBS.
    Case presentation: We present a case of a 16-year-old young man with a history of quick jerks since childhood. They progressed gradually over the years involving the entire body and interfering with most of his daily activities. He had no dystonia. Genetic testing identified a single base deletion in exon 3 of the SGCE gene, considered very likely pathogenic. After unsuccessfully trying several oral medications, he underwent DBS of the globus pallidus internus (GPi). His Unified Myoclonus Rating Scale score during rest and with action improved by 92.8% and 82.6%, respectively.
    Discussion: The striking effect of DBS on myoclonic jerks confirms the superior benefit of DBS over oral medications. Further study is needed to determine the role of mutation status in predicting DBS response, especially considering that myoclonus-dystonia is genetically heterogeneous.
    Conclusion: Our case confirms the poor response to oral medications and supports the use of GPi DBS for patients with genetically confirmed myoclonus-dystonia and isolated-myoclonus phenotype. In addition, our case represents familial myoclonus-dystonia due to a novel SGCE mutation.
    Language English
    Publishing date 2020-04-09
    Publishing country New Zealand
    Document type Journal Article
    ISSN 2193-8253
    ISSN 2193-8253
    DOI 10.1007/s40120-020-00186-4
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Alberta Spinal Muscular Atrophy Newborn Screening-Results from Year 1 Pilot Project.

    Niri, Farshad / Nicholls, Jessie / Baptista Wyatt, Kelly / Walker, Christine / Price, Tiffany / Kelln, Rhonda / Hume, Stacey / Parboosingh, Jillian / Lilley, Margaret / Kolski, Hanna / Ridsdale, Ross / Muranyi, Andrew / Mah, Jean K / Bulman, Dennis E

    International journal of neonatal screening

    2023  Volume 9, Issue 3

    Abstract: Spinal muscular atrophy (SMA) is a progressive neuromuscular disease caused by biallelic pathogenic/likely pathogenic variants of ... ...

    Abstract Spinal muscular atrophy (SMA) is a progressive neuromuscular disease caused by biallelic pathogenic/likely pathogenic variants of the
    Language English
    Publishing date 2023-07-27
    Publishing country Switzerland
    Document type Journal Article
    ISSN 2409-515X
    ISSN (online) 2409-515X
    DOI 10.3390/ijns9030042
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Estimate of the contemporary live-birth prevalence of recurrent 22q11.2 deletions: a cross-sectional analysis from population-based newborn screening.

    Blagojevic, Christina / Heung, Tracy / Theriault, Mylene / Tomita-Mitchell, Aoy / Chakraborty, Pranesh / Kernohan, Kristin / Bulman, Dennis E / Bassett, Anne S

    CMAJ open

    2021  Volume 9, Issue 3, Page(s) E802–E809

    Abstract: Background: Although pathogenic 22q11.2 deletions are an important cause of developmental delays and lifelong disease burden, their variable and complex clinical expression contributes to under-recognition, delayed molecular diagnosis and uncertainty ... ...

    Abstract Background: Although pathogenic 22q11.2 deletions are an important cause of developmental delays and lifelong disease burden, their variable and complex clinical expression contributes to under-recognition, delayed molecular diagnosis and uncertainty about prevalence. We sought to estimate the contemporary live-birth prevalence of typical 22q11.2 deletions using a population-based newborn screening sample and to examine data available for associated clinical features.
    Methods: Using DNA available from an unbiased sample of about 12% of all dried blood spots collected for newborn screening in Ontario between January 2017 and September 2018, we prospectively screened for 22q11.2 deletions using multiplex quantitative polymerase chain reaction assays and conducted independent confirmatory studies. We used cross-sectional analyses to compare available clinical and T-cell receptor excision circle (TREC, used in newborn screening for severe combined immunodeficiency) data between samples with and without 22q11.2 deletions.
    Results: The estimated minimum prevalence of 22q11.2 deletions was 1 in 2148 (4.7 per 10 000) live births (95% confidence interval [CI] 2.5 to 7.8 per 10 000), based on a total of 30 074 samples screened, with 14 having confirmed 22q11.2 deletions. Of term singletons, samples with 22q11.2 deletions had significantly younger median maternal age (25.5 v. 32.0 yr, difference -6.5 yr, 95% CI -7 to -2 yr), a greater proportion with small birth weight for gestational age (odds ratio 7.00, 95% CI 2.36 to 23.18) and lower median TREC levels (108.9 v. 602.5 copies/3 μL,
    Interpretation: These results indicate that the 22q11.2 deletion syndrome is one of the most common of rare genetic conditions and may be associated with relatively younger maternal ages and with prenatal growth abnormalities. The findings support the public health importance of early - prenatal and neonatal - diagnosis that would enable prompt screening for and management of well-known actionable features associated with 22q11.2 deletions.
    MeSH term(s) Cross-Sectional Studies ; Developmental Disabilities/diagnosis ; Developmental Disabilities/epidemiology ; Developmental Disabilities/etiology ; DiGeorge Syndrome/diagnosis ; DiGeorge Syndrome/epidemiology ; DiGeorge Syndrome/genetics ; Early Medical Intervention ; Female ; Gestational Age ; Humans ; Infant, Low Birth Weight ; Infant, Newborn ; Live Birth/epidemiology ; Male ; Maternal Age ; Molecular Diagnostic Techniques/methods ; Molecular Diagnostic Techniques/statistics & numerical data ; Neonatal Screening/methods ; Ontario/epidemiology ; Prenatal Diagnosis/methods ; Prevalence ; Severe Combined Immunodeficiency/diagnosis ; Severe Combined Immunodeficiency/epidemiology ; Severe Combined Immunodeficiency/genetics
    Language English
    Publishing date 2021-08-17
    Publishing country Canada
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2701622-5
    ISSN 2291-0026 ; 2291-0026
    ISSN (online) 2291-0026
    ISSN 2291-0026
    DOI 10.9778/cmajo.20200294
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Genotypes of chronic progressive external ophthalmoplegia in a large adult-onset cohort.

    Heighton, Julia N / Brady, Lauren I / Sadikovic, Bekim / Bulman, Dennis E / Tarnopolsky, Mark A

    Mitochondrion

    2019  Volume 49, Page(s) 227–231

    Abstract: Chronic progressive external ophthalmoplegia (CPEO) is a common presentation of mitochondrial disease. We performed a retrospective evaluation of the molecular genetic testing and genotype-phenotype correlations in a large cohort of adult-onset CPEO ... ...

    Abstract Chronic progressive external ophthalmoplegia (CPEO) is a common presentation of mitochondrial disease. We performed a retrospective evaluation of the molecular genetic testing and genotype-phenotype correlations in a large cohort of adult-onset CPEO patients (N = 111). One hundred percent of patients tested had at least one mitochondrial DNA (mtDNA) deletion. Genetic testing of nuclear genes encoding mitochondrial proteins identified pathogenic/likely pathogenic variants likely to be associated with CPEO in 7.6% of patients. As expected, the nuclear gene most associated with DNA variation was POLG. A single likely pathogenic mitochondrial DNA variant (m.12278T>C) was identified in two unrelated patients. No significant differences were noted in the clinical phenotypes of patients with pathogenic or likely pathogenic nuclear variants in comparison to those with negative nuclear gene testing. Analysis of deletion size and heteroplasmy in muscle-derived mtDNA showed significant correlations with age of symptom onset but not disease severity (number of canonical CPEO features). Results suggest that smaller mtDNA deletions (p = 0.0127, r
    MeSH term(s) Adult ; Age of Onset ; Base Sequence ; Chronic Disease ; DNA Polymerase gamma/genetics ; DNA, Mitochondrial/genetics ; Female ; Genetic Variation ; Genotype ; Humans ; Male ; Middle Aged ; Ophthalmoplegia/genetics ; Point Mutation ; Sequence Deletion
    Chemical Substances DNA, Mitochondrial ; DNA Polymerase gamma (EC 2.7.7.7) ; POLG protein, human (EC 2.7.7.7)
    Language English
    Publishing date 2019-09-12
    Publishing country Netherlands
    Document type Clinical Trial ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2056923-3
    ISSN 1872-8278 ; 1567-7249
    ISSN (online) 1872-8278
    ISSN 1567-7249
    DOI 10.1016/j.mito.2019.09.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Time-dependent decline of T-cell receptor excision circle levels in ZAP-70 deficiency.

    Suresh, Sneha / Dadi, Harjit / Reid, Brenda / Vong, Linda / Bulman, Dennis E / Roifman, Chaim M

    The journal of allergy and clinical immunology. In practice

    2019  Volume 8, Issue 2, Page(s) 806–808.e2

    MeSH term(s) Humans ; Receptors, Antigen, T-Cell/genetics ; ZAP-70 Protein-Tyrosine Kinase/deficiency ; ZAP-70 Protein-Tyrosine Kinase/genetics
    Chemical Substances Receptors, Antigen, T-Cell ; ZAP-70 Protein-Tyrosine Kinase (EC 2.7.10.2)
    Language English
    Publishing date 2019-08-23
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2843237-X
    ISSN 2213-2201 ; 2213-2198
    ISSN (online) 2213-2201
    ISSN 2213-2198
    DOI 10.1016/j.jaip.2019.08.018
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Correction to: Missense mutations in ITPR1 cause autosomal dominant congenital nonprogressive spinocerebellar ataxia.

    Huang, Lijia / Warman-Chardon, Jodi / Carter, Melissa T / Friend, Kathie L / Dudding, Tracy E / Schwartzentruber, Jeremy / Zou, Ruobing / Schofield, Peter W / Douglas, Stuart / Bulman, Dennis E / Boycott, Kym M

    Orphanet journal of rare diseases

    2022  Volume 17, Issue 1, Page(s) 143

    Language English
    Publishing date 2022-03-29
    Publishing country England
    Document type Published Erratum
    ZDB-ID 2225857-7
    ISSN 1750-1172 ; 1750-1172
    ISSN (online) 1750-1172
    ISSN 1750-1172
    DOI 10.1186/s13023-022-02297-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Ataxia Telangiectasia Diagnosed on Newborn Screening-Case Cohort of 5 Years' Experience.

    Mandola, Amarilla B / Reid, Brenda / Sirror, Raga / Brager, Rae / Dent, Peter / Chakroborty, Pranesh / Bulman, Dennis E / Roifman, Chaim M

    Frontiers in immunology

    2019  Volume 10, Page(s) 2940

    Abstract: Ataxia telangiectasia (AT) is a genetic condition caused by mutations ... ...

    Abstract Ataxia telangiectasia (AT) is a genetic condition caused by mutations involving
    MeSH term(s) Ataxia Telangiectasia/diagnosis ; Ataxia Telangiectasia/genetics ; Ataxia Telangiectasia/immunology ; Ataxia Telangiectasia/therapy ; Ataxia Telangiectasia Mutated Proteins/genetics ; Ataxia Telangiectasia Mutated Proteins/immunology ; B-Lymphocytes/immunology ; B-Lymphocytes/pathology ; Case-Control Studies ; Humans ; Immunoglobulins, Intravenous/administration & dosage ; Infant ; Infant, Newborn ; Male ; Mutation ; Neonatal Screening ; Ontario ; Severe Combined Immunodeficiency/diagnosis ; Severe Combined Immunodeficiency/genetics ; Severe Combined Immunodeficiency/immunology ; Severe Combined Immunodeficiency/therapy ; T-Lymphocytes/immunology ; T-Lymphocytes/pathology ; Vaccination ; Whole Genome Sequencing
    Chemical Substances Immunoglobulins, Intravenous ; ATM protein, human (EC 2.7.11.1) ; Ataxia Telangiectasia Mutated Proteins (EC 2.7.11.1)
    Language English
    Publishing date 2019-12-20
    Publishing country Switzerland
    Document type Case Reports ; Clinical Trial ; Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2606827-8
    ISSN 1664-3224 ; 1664-3224
    ISSN (online) 1664-3224
    ISSN 1664-3224
    DOI 10.3389/fimmu.2019.02940
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: An evaluation of genetic causes and environmental risks for bilateral optic atrophy.

    Chen, Andrew T / Brady, Lauren / Bulman, Dennis E / Sundaram, Arun N E / Rodriguez, Amadeo R / Margolin, Edward / Waye, John S / Tarnopolsky, Mark A

    PloS one

    2019  Volume 14, Issue 11, Page(s) e0225656

    Abstract: Purpose: To assess the clinical utility of next-generation sequencing (NGS) for the diagnosis of patients with optic atrophy (OA).: Design: Retrospective cohort study.: Methods: 97 patients were referred to the McMaster University Medical Center ( ... ...

    Abstract Purpose: To assess the clinical utility of next-generation sequencing (NGS) for the diagnosis of patients with optic atrophy (OA).
    Design: Retrospective cohort study.
    Methods: 97 patients were referred to the McMaster University Medical Center (Hamilton, Ontario) for evaluation of bilateral OA. All patients were sent for NGS including a 22 nuclear gene panel and/or complete mitochondrial DNA (mtDNA) sequencing. Positive genetic test results and abnormal vibration sensation were compared in patients +/- environmental exposures or a family history.
    Results: 19/94 (20.2%) had a positive nuclear variant, of which 15/19 (78.9%) were in the OPA1 gene. No positive mtDNA variants were identified. The detection of a positive genetic variant was significantly different in patients who reported excessive ethanol use, but not in patients who smoke (0/19 (0%) vs. 19/78 (24.4%), P = 0.0164 and 4/22 (18.2%) vs. 15/74 (20.3%), P = 0.829, respectively). Patients with a positive family history were more likely to have a positive genetic variant compared to patients with a negative family history (P = 0.0112). There were significantly more excessive drinkers with an abnormal vibration sensation (P = 0.026), and with a similar trend in smokers (P = 0.074).
    Conclusions: All positive genetic variants were identified in nuclear genes. We identified a potential independent pathophysiological link between a history of excessive ethanol consumption and bilateral OA. Further investigations should evaluate and identify potential environmental risk factors for OA.
    MeSH term(s) Aconitate Hydratase/genetics ; Alcohol Drinking ; DNA, Mitochondrial/chemistry ; DNA, Mitochondrial/genetics ; DNA, Mitochondrial/metabolism ; Environmental Exposure ; GTP Phosphohydrolases/genetics ; Genetic Variation ; High-Throughput Nucleotide Sequencing ; Humans ; Membrane Proteins/genetics ; Optic Atrophy/genetics ; Optic Atrophy/pathology ; Retrospective Studies ; Risk Factors ; Sequence Analysis, DNA ; Smoking
    Chemical Substances DNA, Mitochondrial ; Membrane Proteins ; wolframin protein ; GTP Phosphohydrolases (EC 3.6.1.-) ; OPA1 protein, human (EC 3.6.1.-) ; ACO2 protein, human (EC 4.2.1.3) ; Aconitate Hydratase (EC 4.2.1.3)
    Language English
    Publishing date 2019-11-25
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ISSN 1932-6203
    ISSN (online) 1932-6203
    DOI 10.1371/journal.pone.0225656
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Retrospective testing of respiratory specimens for COVID-19 to assess for earlier SARS-CoV-2 infections in Alberta, Canada.

    Kanji, Jamil N / Diggle, Mathew / Bulman, Dennis E / Hume, Stacey / Taylor, Sherry / Kelln, Rhonda / Haase, Shelagh / Tomaszewski, Robert / Walker, Christine / Pabbaraju, Kanti / Li, Vincent / Croxen, Matthew / Zelyas, Nathan / Hinshaw, Deena / Tipples, Graham

    Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada

    2021  Volume 6, Issue 1, Page(s) 10–15

    Abstract: Background: The first case of coronavirus disease 2019 (COVID-19) in Alberta, Canada, was confirmed on March 5, 2020. Because the virus testing criteria had changed significantly over this time period, we wanted to ascertain whether previous cases of ... ...

    Abstract Background: The first case of coronavirus disease 2019 (COVID-19) in Alberta, Canada, was confirmed on March 5, 2020. Because the virus testing criteria had changed significantly over this time period, we wanted to ascertain whether previous cases of COVID-19 had been missed in the province.
    Methods: Our aim was to retrospectively evaluate specimens submitted for respiratory virus testing from December 1, 2019, through March 7, 2020, for undetected severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections before the first confirmed case.
    Results: Testing of 23,517 samples (representing 23,394 patients) identified 1 patient positive for SARS-CoV-2. This specimen was collected on February 24, 2020, from a patient with symptoms consistent with COVID-19 who had recently returned from the western United States. Phylogenetic analysis confirmed this viral isolate belonged to lineage B.1. The epidemiology of this case is consistent with those of other early cases before sustained community transmission, which included a travel history outside of Canada.
    Conclusion: This exercise provides support that local public health pandemic planning was satisfactory and timely.
    Language English
    Publishing date 2021-05-03
    Publishing country Canada
    Document type Journal Article
    ISSN 2371-0888
    ISSN (online) 2371-0888
    DOI 10.3138/jammi-2020-0035
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: The PARLance of Parkinson disease.

    McQuibban, G Angus / Bulman, Dennis E

    Autophagy

    2011  Volume 7, Issue 7, Page(s) 790–792

    Abstract: Mitochondrial biology has recently emerged as a key regulatory event in Parkinson disease (PD). Notably, defects in the clearance of damaged mitochondria, termed mitophagy, have been recently highlighted as a possible mechanistic explanation for neuronal ...

    Abstract Mitochondrial biology has recently emerged as a key regulatory event in Parkinson disease (PD). Notably, defects in the clearance of damaged mitochondria, termed mitophagy, have been recently highlighted as a possible mechanistic explanation for neuronal loss. We have recently identified the mitochondrial rhomboid, termed PARL, as a regulator of the cells mitophagic response. Further, we have identified PD-linked mutations at a functional site in the PARL gene. Here we discuss the benefit of combining molecular genetic and cell biology approaches in understanding human disease.
    MeSH term(s) Autophagy ; Humans ; Mitochondria/metabolism ; Mitochondrial Proteins/metabolism ; Models, Biological ; Parkinson Disease/enzymology ; Parkinson Disease/genetics ; Parkinson Disease/metabolism ; Parkinson Disease/pathology ; Protein Kinases/metabolism
    Chemical Substances Mitochondrial Proteins ; Protein Kinases (EC 2.7.-) ; PTEN-induced putative kinase (EC 2.7.11.1)
    Language English
    Publishing date 2011-07-01
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2454135-7
    ISSN 1554-8635 ; 1554-8627
    ISSN (online) 1554-8635
    ISSN 1554-8627
    DOI 10.4161/auto.7.7.15614
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top